{
  "guid": "http://files.libertyfund.org/econtalk/y2018/Rajkumarcancer.mp3",
  "title": "Vincent Rajkumar on the High Price of Cancer Drugs",
  "description": "<p>Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment. Rajkumar explains how little a role market forces play in setting prices and what might be done to improve the situation.</p>\n",
  "pubDate": "Mon, 9 Apr 2018 06:30:00 +0000",
  "author": "webmaster@econlib.org (EconTalk: Russ Roberts)",
  "link": "https://www.econtalk.org/vincent-rajkumar-on-the-high-price-of-cancer-drugs/",
  "content:encoded": "<p>Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment. Rajkumar explains how little a role market forces play in setting prices and what might be done to improve the situation.</p>\n",
  "enclosure": "",
  "itunes:title": "Vincent Rajkumar on the High Price of Cancer Drugs",
  "itunes:author": "EconTalk: Russ Roberts",
  "itunes:duration": "01:12:38",
  "itunes:summary": "Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment. Rajkumar explains how little a role market forces play in setting prices and what might be done to improve the situation.",
  "itunes:subtitle": "Can a life-saving drug be too expensive? What explains the high price of cancer drugs? Dr. Vincent Rajkumar of the Mayo Clinic talks with EconTalk host Russ Roberts about the high price of cancer drugs--drugs that can cost an American with cancer $300,000 per year and require multiple years of treatment. Rajkumar explains how little a role market forces play in setting prices and what might be done to improve the situation.",
  "itunes:keywords": "economics, regulations, drug costs, pharmaceuticals, econlib, patents, health care, vincent rajkumar, medicine, insurance",
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "itunes:episode": 624
}